CARLSBAD, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for disease research and drug discovery, and ScienceXperts, Inc., a provider of software tools for bioscience studies, today announced the launch of CytoGenie™, a knowledge-based software tool that simplifies the design of flow cytometry experiments, including multicolor protocols whose complexity amplifies dramatically as more parameters are detected.
CytoGenie software is the result of a collaboration between Invitrogen, and Drs. Leonard and Leonore Herzenberg, founders of ScienceXperts, Inc. and pioneers in flow cytometry, an essential technique used in cell biology and immunology. The software package, available at www.invitrogen.com/flowcytometry as a free resource to scientists, greatly simplifies the process of selecting the optimal reagent to maximize the performance and results from the flow cytometer.
“Flow cytometry is an extremely powerful, yet complex technique,” noted Kip Miller, Senior Vice President, Biodiscovery, for Invitrogen. “We are very excited and pleased to collaborate with ScienceXperts, to develop this software-assisted reagent selection tool that dramatically simplifies the flow cytometry workflow, from experimental design to optimized reagent selection.”
CytoGenie software integrates Invitrogen’s broad portfolio of fluorescent reagents through a direct link to the online catalog featuring thousands of products optimized for use in flow cytometry. CytoGenie’s knowledge-base takes the guesswork out of determining which dye combinations are best suited for use on a particular flow cytometer configuration. In addition, CytoGenie enables scientists to easily purchase reagents through Invitrogen online, and to manage the reagent inventory used in those protocols.
“With advanced techniques such as multicolor analysis, flow cytometry continues to push the envelope,” said Dr. Leonard Herzenberg, professor emeritus at Stanford University and a founding member of Invitrogen’s scientific advisory board for immunology and flow cytometry. “However, researchers are often mystified by the complexity of the technique. CytoGenie is designed to take the guesswork out of developing multicolor flow cytometry protocols, allowing scientists to tackle the most difficult cellular analysis questions facing them.”
Dr. Leonard Herzenberg is also this year's Kyoto Prize Laureate for advanced technology, and is being honored this week in San Diego during the sixth annual Kyoto Laureate Symposium, a three-day celebration of the lives and works of those receiving the Kyoto Prize.
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company is celebrating 20 years of accelerating scientific discovery. Invitrogen globally employs approximately 5,000 scientists and other professionals and had revenues of more than $1.26 billion in 2006. For more information, visit www.invitrogen.com.
Founded in 2006 by Kyoto Prize recipient Dr. Leonard A. Herzenberg and his Stanford University colleagues, Dr. Leonore A. Herzenberg and Dr. Mark A. Musen, ScienceXperts provides computer aided design tools and advanced data archiving capabilities to researchers in the life sciences. ScienceXperts innovations include CytoGenieBasic, CytoGeniePro and the ScienceDataStore. Its flagship product, CytoGenie, introduces biomedical scientists to the full power of computer aided design, or CAD, already an essential tool in architecture, engineering and other design spheres. Driven by the FacsXpert engine developed at Stanford, this cutting-edge knowledge-based software service helps scientists plan, run, analyze and share basic and clinical flow cytometry experiments. Its companion product, ScienceDataStore, also developed at Stanford, provides standards-compliant archival storage for flow cytometry and other large data sets, keeping these permanently associated with CytoGenie and other experiment descriptions. The management team is led by CEO Bruce Goldman. ScienceXperts is based in Palo Alto, California, and currently has business operations in three continents.
Safe Harbor Statement
Certain statements contained in this press release are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is Invitrogen’s intent that such statements be protected by the safe harbor created thereby. Forward-looking statements include, but are not limited to: 1) Invitrogen’s software tool will simplify the design of flow cytometry experiments; 2) Invitrogen’s software tool will take the guesswork out of determining which dye combinations are best suited for use on a particular flow cytometer configuration. Potential risks and uncertainties include, but are not limited to, the risks: a) the unpredictability of future demand for this software and related products, as well as other risks and uncertainties detailed from time to time in Invitrogen's Securities and Exchange Commission filings.